Medicare Enrolled
Dr. Sultan Yusufzai, M.D.
Student in an Organized Health Care Education/Training Program · Rancho Cordova, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yusufzai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yusufzai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yusufzai
Dr. Sultan Yusufzai is a student in an organized health care education/training program specialist in Rancho Cordova, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Yusufzai performed 1,231 Medicare services across 762 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yusufzai received a total of $10,688 from 60 pharmaceutical and/or device companies across 559 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yusufzai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 15% volume in CA
$10,688 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,231
Medicare services
Top 15% in CA for student in an organized health care education/training program
762
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
511 | $95 | $176 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
168 | $51 | $69 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
85 | $138 | $245 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
82 | $125 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
74 | $68 | $123 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
52 | $53 | $146 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
44 | $65 | $179 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $120 | $268 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
31 | $45 | $120 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
29 | $12 | $43 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
24 | $6 | $16 |
| Annual depression screening | 19 | $20 | $30 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
18 | $238 | $400 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
17 | $30 | $31 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
17 | $33 | $39 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
17 | $34 | $77 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,688
Total received (2018-2024)
Avg $1,527/year across 7 years
Top 3% in CA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
559
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,676 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,512
2023
$2,802
2022
$2,647
2021
$1,148
2020
$806
2019
$630
2018
$143
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$389
GlaxoSmithKline, LLC.
$369
AstraZeneca Pharmaceuticals LP
$330
JAZZ PHARMACEUTICALS INC.
$217
Novo Nordisk Inc
$177
AIMMUNE THERAPEUTICS, INC.
$174
Lilly USA, LLC
$172
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
Amgen Inc.
$134
Bayer Healthcare Pharmaceuticals Inc.
$81
Exact Sciences Corporation
$75
Otsuka America Pharmaceutical, Inc.
$71
Dexcom, Inc.
$44
Astellas Pharma US Inc
$28
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$23
PFIZER INC.
$22
Smith+Nephew, Inc.
$22
Phadia US Inc.
$20
Sumitomo Pharma America, Inc.
$18
Top 3 companies account for 43.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,511
AstraZeneca Pharmaceuticals LP
$902
ABBVIE INC.
$890
AbbVie Inc.
$779
Lilly USA, LLC
$751
Novo Nordisk Inc
$731
Novartis Pharmaceuticals Corporation
$440
Amgen Inc.
$338
Bayer Healthcare Pharmaceuticals Inc.
$287
Boehringer Ingelheim Pharmaceuticals, Inc.
$278
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$267
PFIZER INC.
$232
JAZZ PHARMACEUTICALS INC.
$217
Bayer HealthCare Pharmaceuticals Inc.
$213
Amarin Pharma Inc.
$196
Sunovion Pharmaceuticals Inc.
$186
AIMMUNE THERAPEUTICS, INC.
$174
Nestle HealthCare Nutrition Inc.
$160
Exact Sciences Corporation
$145
Astellas Pharma US Inc
$140
Otsuka America Pharmaceutical, Inc.
$129
Avanir Pharmaceuticals, Inc.
$116
Merck Sharp & Dohme Corporation
$107
SANOFI-AVENTIS U.S. LLC
$105
Janssen Pharmaceuticals, Inc
$104
Esperion Therapeutics, Inc.
$95
Neurocrine Biosciences, Inc.
$92
UROVANT SCIENCES INC
$92
E.R. Squibb & Sons, L.L.C.
$92
ITI, Inc.
$78
Siemens Medical Solutions USA, Inc.
$74
Axsome Therapeutics, Inc.
$69
ACADIA Pharmaceuticals Inc
$49
Jazz Pharmaceuticals Inc.
$48
Dexcom, Inc.
$44
Phadia US Inc.
$35
Biohaven Pharmaceuticals, Inc.
$34
Scilex Pharmaceuticals Inc.
$34
Sumitomo Pharma America, Inc.
$32
Kowa Pharmaceuticals America, Inc.
$30
Merck Sharp & Dohme LLC
$30
Allergan Inc.
$29
Eisai Inc.
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Kyowa Kirin, Inc.
$26
Gilead Sciences, Inc.
$24
VBI Vaccine (Delaware) Inc.
$24
Sun Pharmaceutical Industries Inc.
$23
Smith+Nephew, Inc.
$22
Otsuka Pharmaceutical Development & Commercialization, Inc.
$18
Alexion Pharmaceuticals, Inc.
$18
IRONWOOD PHARMACEUTICALS, INC
$18
Abbott Laboratories
$17
Supernus Pharmaceuticals, Inc.
$15
Synergy Pharmaceuticals Inc
$14
Alfasigma USA, Inc.
$14
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$13
Teva Pharmaceuticals USA, Inc.
$13
Takeda Pharmaceuticals U.S.A., Inc.
$12
NOVARTIS PHARMACEUTICALS CORPORATION
$12
Top 3 companies account for 30.9% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AMYVID · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · Aduhelm · AirDuo Digihaler · Auvelity · BAQSIMI · BELBUCA · BELSOMRA · BREO · BREZTRI · BYDUREON · CAPLYTA · CHANTIX · COLOGUARD · CREON · Cologuard Collection Kit · Dayvigo · Descovy · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · EZALLOR SPRINKLE · FARXIGA · FREESTYLE LIBRE 2 · GEMTESA · INGREZZA · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · KAPSPARGO · Kerendia · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OFEV · OXTELLAR XR · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREMARIN · PREVNAR 20 · PreHevbrio · QULIPTA · REXULTI · RYBELSUS · Renasys · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SYMBICORT · Syva Rapids Instrument · TRELEGY ELLIPTA · TRULICITY · Trintellix · Trulance · UBRELVY · ULTOMIRIS · VERQUVO · VIBERZI · VOWST · VRAYLAR · Vascepa · Veozah · XARELTO · XIFAXAN · XYWAV · ZENPEP · ZEPBOUND · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for student in an organized health care education/training program in CA.
Geographic Context
Student in an organized health care education/training programs within 10 mi
2,773
Per 100K population
175.1
County median income
$88,724
Nearest hospital
MERCY SAN JUAN MEDICAL CENTER
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yusufzai is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 3% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yusufzai experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Yusufzai performed 511 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yusufzai receive payments from pharmaceutical companies?
Yes. Dr. Yusufzai received a total of $10,688 from 60 companies across 559 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yusufzai's costs compare to other student in an organized health care education/training programs in Rancho Cordova?
Dr. Yusufzai's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yusufzai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Rancho Cordova
Browse student in an organized health care education/training programs in Rancho Cordova ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in CA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in CA
Which CA student in an organized health care education/training programs receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology